Apogee Therapeutics (APGE) Other Working Capital Changes (2023 - 2026)

Apogee Therapeutics (APGE) has 4 years of Other Working Capital Changes data on file, last reported at $2.5 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $2.5 million, up 345.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (up 5.27% YoY), and the FY2025 annual result was $2.1 million, down 65.36% from the prior year.
• Other Working Capital Changes climbed to $2.5 million in Q1 2026 per APGE's latest filing, from -$1.6 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $5.7 million in Q3 2025 and troughed at -$3.7 million in Q4 2023.
• A 4-year average of $800461.5 and a median of $596000.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes sank 697.73% in 2024, then surged 345.56% in 2026.
• A 4-year view of Other Working Capital Changes shows it stood at -$3.7 million in 2023, then surged by 116.23% to $596000.0 in 2024, then sank by 375.5% to -$1.6 million in 2025, then soared by 251.64% to $2.5 million in 2026.
• Business Quant data shows APGE's Other Working Capital Changes at $2.5 million in Q1 2026, -$1.6 million in Q4 2025, and $5.7 million in Q3 2025.